REMICADE® goes beyond temporary relief of symptoms and provides lasting remission. Clinical studies have demonstrated that REMICADE® helps eliminate steroid use and helps heal the intestinal lining. Individual results may vary.
REMICADE® can lower your child's ability to fight infections. Serious and sometimes fatal events can occur. There have been reports of serious infections including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that have spread throughout the body. Lymphoma, including a fatal kind called hepatosplenic T-cell lymphoma, and other cancers have been reported in children and adults taking REMICADE®. Some people with heart failure should not take REMICADE®. Other serious side effects include hepatitis B, liver injury, blood problems, allergic reactions, nervous system problems, or lupus-like syndrome. To learn more about these and other risks, please read the Important Safety Information  and the Medication Guide , and talk with your doctor.
REMICADE® is administered as a 2-hour IV infusion so that it goes right into the bloodstream to get to work. Your healthcare professional will carefully calculate and customize the right dose based on your child's body weight. After the 3 starter doses, your child will remain on maintenance therapy, which is just once every 8 weeks. That could be as few as 6 times a year.
REMICADE®, like other medicines that affect the immune system, is a strong medicine that can cause serious side effects such as cancer and serious infections caused by viruses, fungi, or bacteria that have spread throughout the body, including tuberculosis (TB) and histoplasmosis. Some of these side effects have been fatal. For more information about these and other serious side effects, please read the Important Safety Information  for REMICADE® and the Medication Guide  for REMICADE®, and talk to your doctor. The most common side effects of REMICADE® include: respiratory infections, headache, rash, coughing, and stomach pain.
You should discuss any questions or concerns about your child's health with your doctor. Please read the Important Safety Information  and the Medication Guide  for REMICADE® that includes the most common and the most serious side effects, related symptoms and when to talk to your doctor or seek medical care. If you seek medical care from a healthcare professional other than the doctor who prescribed REMICADE®, it is important to let them know about your child's medical history and any current medications, including REMICADE®.
REMICADE® has been used to treat more than 1.3 million people worldwide with inflammatory conditions such as Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis. Its safety profile has been evaluated in clinical trials conducted over the past 18 years. REMICADE® is not for everyone. Talk to your doctor to see if REMICADE® is right for your child.
REMICADE® is covered by most insurance plans, including commercial insurers, Medicare, and Medicaid. Coverage policies may vary by insurer or even between plans offered by the same insurer. If you have any questions about insurance coverage or reimbursement, you should first call your insurance company or Medicare. If you have questions or concerns, or if you need additional information related to medical coverage or patient assistance for REMICADE®, you may call AccessOne® at (888) ACCESS-1 (222-3771), Monday through Friday, 8:00 AM to 8:00 PM E.T.
Only your doctor can recommend a course of treatment after checking your health condition. REMICADE® (infliximab) can cause serious side effects such as lowering your ability to fight infections. Some patients, especially those 65 years and older, have had serious infections caused by viruses, fungi or bacteria that have spread throughout the body, including tuberculosis (TB) and histoplasmosis. Some of these infections have been fatal. Your doctor should monitor you closely for signs and symptoms of TB during treatment with REMICADE®.
Unusual cancers have been reported in children and teenage patients taking TNF-blocker medicines. Hepatosplenic T-cell lymphoma, a rare form of fatal lymphoma, has occurred mostly in teenage or young adult males with Crohn’s disease or ulcerative colitis who were taking REMICADE® and azathioprine or 6-mercaptopurine. For children and adults taking TNF blockers, including REMICADE®, the chances of getting lymphoma or other cancers may increase.
You should discuss any concerns about your health and medical care with your doctor.
What should I tell my doctor before I take REMICADE®?
You should let your doctor know if you have or ever had any of the following:
Also tell your doctor if you:
What should I watch for and talk to my doctor about before or while taking REMICADE®?
The following serious (sometimes fatal) side effects have been reported in people taking REMICADE®.
You should tell your doctor right away if you have any of the signs listed below:
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.